Kang Minyong, Kim Myong, Choo Min Soo, Paick Jae-Seung, Oh Seung-June
Department of Urology, Seoul National University Bundang Hospital, Seong-nam si, Gyeonggi-do, Republic of Korea.
Department of Urology, Asan Medical Center, Seoul, Republic of Korea.
Urology. 2016 Mar;89:96-102. doi: 10.1016/j.urology.2015.11.027. Epub 2015 Dec 9.
To investigate the clinical and urodynamic features of patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) according to their prostate size.
We analyzed 2039 LUTS/BPH patients who underwent urodynamic study between October 2004 and August 2013. We divided the patients into three groups according to their prostate size: small (≤30 mL), moderately enlarged (31-80 mL), and large prostate (≥81 mL) groups. We compared the groups regarding age, International Prostatic Symptom Score, maximal flow rate (Qmax), postvoided residual (PVR), serum prostate-specific antigen, prostate volume measured by ultrasonography, and urodynamic findings.
Patients with a small prostate had better urodynamic outcomes than those with larger prostates in overall population. Although the total prostate volume significantly correlated with the bladder outlet obstruction (BOO) index (r = 0.51), BOO patients with a small prostate had similar Qmax, higher PVR, and lower voiding efficiency, compared to those with larger prostates. Moreover, urodynamic parameters indicating bladder abnormalities, including low compliance and involuntary detrusor contraction positivity, were similar among the groups in BOO patients. A higher proportion of detrusor underactivity was also observed in the small prostate group in BOO patients. Finally, when adjusting for potential confounding variables, we identified serum prostate-specific antigen levels (odds ratio, 1.34) and Qmax (odds ratio, 0.77) as significant predictors for BOO in LUTS/BPH patients with a small prostate.
BOO patients with a small prostate showed higher PVR and poor voiding efficiency, as well as similar urodynamic bladder abnormalities, compared to those with moderately enlarged and large prostates.
根据前列腺大小,研究下尿路症状/良性前列腺增生(LUTS/BPH)患者的临床和尿动力学特征。
我们分析了2004年10月至2013年8月间接受尿动力学研究的2039例LUTS/BPH患者。根据前列腺大小将患者分为三组:小前列腺组(≤30 mL)、中度增大组(31 - 80 mL)和大前列腺组(≥81 mL)。我们比较了三组患者的年龄、国际前列腺症状评分、最大尿流率(Qmax)、排尿后残余尿量(PVR)、血清前列腺特异性抗原、超声测量的前列腺体积以及尿动力学检查结果。
总体人群中,小前列腺患者的尿动力学结果优于大前列腺患者。尽管前列腺总体积与膀胱出口梗阻(BOO)指数显著相关(r = 0.51),但与大前列腺的BOO患者相比,小前列腺的BOO患者Qmax相似、PVR更高且排尿效率更低。此外,在BOO患者中,提示膀胱异常的尿动力学参数,包括低顺应性和逼尿肌不自主收缩阳性率,在各组之间相似。在BOO患者的小前列腺组中也观察到较高比例的逼尿肌活动减退。最后,在调整潜在混杂变量后,我们确定血清前列腺特异性抗原水平(比值比,1.34)和Qmax(比值比,0.77)是小前列腺LUTS/BPH患者BOO的重要预测因素。
与中度增大和大前列腺的BOO患者相比,小前列腺的BOO患者表现出更高的PVR和较差的排尿效率,以及相似的尿动力学膀胱异常。